Navigation Links
Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010
Date:6/13/2010

RIDGEFIELD, Conn., June 13 /PRNewswire/ -- Telmisartan, an angiotensin receptor blocker, is one of the best researched drugs worldwide. It has been studied in clinical trials in more than 50,000 patients. Its positive safety profile has been confirmed also in a market exposure of 34.5 million patient years. Convincing safety data for patients with a high cardiovascular risk were collected in the three long-term outcome trials ONTARGET, PRoFESS and TRANSCEND which followed some of the patients for up to five years. Following rigorous assessment of the data from these studies it was concluded that there was no association with an increased risk of cancer in the telmisartan arms.

Sipahi et al published a meta-analysis in the June issue of Lancet Oncology, claiming that angiotensin receptor blockers (ARBs) used to lower hypertension are associated with a modestly increased risk of new cancer diagnosis. The finding is mainly based on the combination arm of telmisartan and ramipril, an angiotensin converting enzyme (ACE)-inhibitor, and not on the trial arms of each compound separately.

Patient health and safety is the primary concern of Boehringer Ingelheim. The company continually monitors safety data for all medical products. Boehringer Ingelheim's comprehensive internal safety data analysis of primary data contradicts the conclusions about an increased risk of potential malignancies mentioned by Sipahi et al.

All outcome studies with telmisartan included patients with cardiovascular risk factors due to age and comorbidities. Specifically, in ONTARGET, with more than 25,000 patients, no statistically significant difference with respect to malignancies was observed in patients treated with telmisartan vs ramipril (HR 1.05, 95%CI 0.94, 1.16).  In TRANSCEND, a 6,000 patient trial, the differe
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. New Boehringer Ingelheim Science Quest Mobile Laboratory Brings Hands-On Science Education to Priority Connecticut Elementary Schools
2. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
3. Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer
4. Boehringer Ingelheim Unveils Diabetes Pipeline
5. Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009
6. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
7. Boehringer Ingelheim Initiates NEwArT Study Comparing Viramune(R) (nevirapine) to a Ritonavir-Boosted Atazanavir-based Regimen in Treatment-Naive HIV Patients
8. Watson Says Appeals Court Affirms Concerta(R) Patent Invalid
9. Beckman Coulter Affirms 2009 Outlook
10. China-Biotics, Inc. Begins Trial Production at New Facility, Affirms 2010 Revenue Guidance
11. Totality of Available Data Reaffirms PROCRIT(R) (Epoetin alfa) Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy-Induced Anemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Legislation passed today by the House Ways ... prevent inappropriate prescriptions in Medicare Part D from crossing ... Medicare Act (PIMA) of 2014 , introduced by Ways ... (R-TX) and Ranking Member Jim McDermott (D-WA), recognizes the ... implement the right policies, said the Pharmaceutical Care Management ...
(Date:2/26/2015)... , Feb. 26, 2015  Spring Bank ... therapeutics for the treatment of Hepatitis B virus ... closing of a $22 million financing. Funds from ... 9200, a novel, broad spectrum antiviral agent derived ... acid hybrid (SMNH) chemistry platform, into Phase II ...
(Date:2/26/2015)... NEW YORK , Feb. 26, 2015 /PRNewswire/ ... Latin America is estimated at ... publisher said that population growth, government insurance, newly ... growth in the region and will continue to ... finding on torresearch into the market and interviews ...
Breaking Medicine Technology:PCMA Statement on the 'Protecting the Integrity of Medicare Act' 2Spring Bank Pharmaceuticals Completes $22 Million Financing 2Kalorama: Led by Brazil, IVD Test Market in Latin America Exceeds 2 Billion 2Kalorama: Led by Brazil, IVD Test Market in Latin America Exceeds 2 Billion 3Kalorama: Led by Brazil, IVD Test Market in Latin America Exceeds 2 Billion 4
(Date:2/27/2015)... VA (PRWEB) February 27, 2015 The ... accepting applications for its next class of Fellows — ... field of radiology business management. , Since 2009, ... significant contributions made by RBMA members to the Association ... a prestigious recognition because each Fellow candidate must meet ...
(Date:2/27/2015)... The report “Polycystic Ovarian Syndrome ... on the therapeutic development for polycystic ovarian syndrome. ... a woman's hormones are out of balance. Polycystic ... girls and young women. The cause of polycystic ... pipelines by identifying new targets and MOAs to ...
(Date:2/27/2015)... February 27, 2015 Prescription Drug ... U.S. Drug Enforcement Agency (DEA). Today, ... continue to utilize the “Take-Back” guidelines for the ... FDA. , Eufaula Prescription Drug Disposal Event , ... Drive in Eufaula, Oklahoma as the “Take-Back” site ...
(Date:2/27/2015)... 27, 2015 ResearchMoz has announced ... the analysis of the cell culture protein surface ... discusses the current scenario and development prospects of ... for the period of 2015 to 2019. , ... , The research report, titled Global Cell ...
(Date:2/27/2015)... VT (PRWEB) February 27, 2015 The ... mitigation plan for alleged violations that date back to ... department was completed as soon as it was approved ... Hermitage didn't agree with the allegations we agreed to ... Hermitage Inn Real Estate Holding Company. , Barnes further ...
Breaking Medicine News(10 mins):Health News:RBMA Issues Call for Fellowship Applicants 2Health News:Polycystic Ovarian Syndrome Therapeutics Pipeline Market H1 2015 Review Report Now Available at RnRMarketResearch.com 2Health News:Polycystic Ovarian Syndrome Therapeutics Pipeline Market H1 2015 Review Report Now Available at RnRMarketResearch.com 3Health News:Polycystic Ovarian Syndrome Therapeutics Pipeline Market H1 2015 Review Report Now Available at RnRMarketResearch.com 4Health News:Narconon Arrowhead Promotes Local Prescription Drug Take Back Day 2Health News:Narconon Arrowhead Promotes Local Prescription Drug Take Back Day 3Health News:Global Cell Culture Protein Surface Coating Industry: Rising Focus towards Stem Cells Research to Trigger Market Growth 2Health News:Global Cell Culture Protein Surface Coating Industry: Rising Focus towards Stem Cells Research to Trigger Market Growth 3Health News:Southern Vermont's Hermitage Club Announces Statement Regarding Vermont Attorney General Lawsuit for Permit Violations 2
... (NYSE: HUN ) will hold a conference call to discuss its ... 11:00 a.m. ET. Fourth quarter and full year 2007 results will be,released ... Call-in number for U.S. participants: ... Call-in number for international participants: (617) 213 - 4868 ...
... Spending Cuts, ALEXANDRIA, Va., Feb. 8 President ... to the future of,health and health care for all ... the nation,s single largest payer of children,s health care ... from,discretionary health programs that children depend on, ranging from ...
... Despite Difficulties, States Rise Against the Status Quo ... - A new report from the,Robert Wood Johnson ... 2008: Rising to the Challenge, outlines 2007 efforts ... to address health care,reform at the state level. ...
... NHS Choices ( http://www.nhs.uk ), the,online ,front ... news service to,help people make sense of the ... Behind the headlines, on NHS Choices,( http://www.nhs.uk/News/Pages/NewsIndex.aspx ), ... the news. The service explains the,facts behind newspaper ...
... Feb. 8 The Integrated,Healthcare Association (IHA) welcomes ... third annual National Pay for Performance Summit at ... summit is the,leading forum on pay for performance ... Leapfrog Group has made outstanding contributions toward the,improvement ...
... finds spouses die sooner in unions where anger is suppressed ... secret to a long marriage is communication, and new research ... , A lengthy study of Midwestern couples finds that those ... the perennially resentful. The couples with the most unexpressed anger ...
Cached Medicine News:Health News:Huntsman to Discuss Fourth Quarter and Full Year 2007 Results on Friday, February 22, 2008 2Health News:Bush Budget Cuts Federal Health Programs Vital to the Health of All Children 2Health News:Bush Budget Cuts Federal Health Programs Vital to the Health of All Children 3Health News:Report Lists Key Policy Questions Facing State, National Health Reform 2Health News:Report Lists Key Policy Questions Facing State, National Health Reform 3Health News:Report Lists Key Policy Questions Facing State, National Health Reform 4Health News:Integrated Healthcare Association Welcomes Leah Binder, New CEO of Leapfrog Group to National Pay for Performance Summit 2Health News:Mutual Resentment in Marriage Can Be Deadly 2Health News:Mutual Resentment in Marriage Can Be Deadly 3
... with concave seats and standard-sized backrests ... like seats, backrests, armrests, and casters ... recommended for the following environments: industry, ... health care and office. • With ...
... Basic ergonomic chairs with concave seats ... • Select options like seats, backrests, ... BTN/1Q-CAB chairs are recommended for the ... room, static control, health care and ...
... chairs with concave seats and standard-sized ... options like seats, backrests, armrests, and ... are recommended for the following environments: ... control, health care and office. • ...
... chairs with concave seats and standard-sized ... options like seats, backrests, armrests, and ... are recommended for the following environments: ... control, health care and office. • ...
Medicine Products: